UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▼ | Disease Ontology |
---|---|---|---|---|---|
B3KMM7 | cDNA FLJ11524 fis, clone HEMBA1002547, highly similar to Agrin |
|
1 | 0 |
|
P36915 | Guanine nucleotide-binding protein-like 1 |
|
1 | 0 |
|
A0A4P2SUA9 | MHC class I antigen |
|
1 | 0 |
|
D3G9J4 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A0A7C4X1 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
F8WEP7 | Fetuin B |
|
1 | 0 |
|
P10767 | Fibroblast growth factor 6 |
|
1 | 0 |
|
A0A0N7A6K8 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
P43116 | Prostaglandin E2 receptor EP2 subtype |
|
4 | 0 | |
C7FDT7 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
P46781 | Small ribosomal subunit protein uS4 |
|
1 | 0 |
|
A0A0A0MRH6 | MIA SH3 domain ER export factor 3 (Fragment) |
|
1 | 0 |
|
B3KQN1 | cDNA FLJ90765 fis, clone THYRO1000584, highly similar to Epididymis-specific alpha-mannosidase |
|
2 | 0 |
|
C9IZN0 | Interleukin 17 receptor B (Fragment) |
|
1 | 0 |
|
A0A6B9HR26 | HLA class I histocompatibility antigen |
|
1 | 0 |
|
B4DSE0 | receptor protein-tyrosine kinase |
|
2 | 0 |
|
B7Z557 | cDNA FLJ53076, highly similar to Hepatocyte growth factor-like protein |
|
1 | 0 |
|
B4DTX0 | cDNA FLJ60891, highly similar to Macrophage colony-stimulating factor 1 |
|
2 | 0 |
|
A0A2U7N6S0 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A3S6RG93 | MHC class I antigen |
|
1 | 0 |
|
A0A0E3DC78 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A5F9ZH82 | Lysosomal acid phosphatase (Fragment) |
|
2 | 0 |
|
O14756 | 17-beta-hydroxysteroid dehydrogenase type 6 |
|
3 | 0 |
|
A0A2I4PZB3 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
Q1T720 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025